Steven Gannon
Director · 2 filings · Latest: Jun 1, 2026
Xenon Pharmaceuticals Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|
XENE | Steven Gannon | Director | Jun 1, 2026 | Tax Withholding | $53.41 | 1,416 | $75.6K | 11,870 | |
XENE | Steven Gannon | Director | Jun 1, 2026 | Option Exercise | — | 2,645 | — | 13,286 | |
XENE | Steven Gannon | Director | May 12, 2026 | Option Exercise | $7.38 | 3,500 | $25.8K | 10,641 | |